Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16


Quantitative Mass Spectrometry Identifies Novel Host Binding Partners for Pathogenic Escherichia coli Type III Secretion System Effectors.

Law RJ, Law HT, Scurll JM, Scholz R, Santos AS, Shames SR, Deng W, Croxen MA, Li Y, de Hoog CL, van der Heijden J, Foster LJ, Guttman JA, Finlay BB.

J Proteome Res. 2016 May 6;15(5):1613-22. doi: 10.1021/acs.jproteome.6b00074. Epub 2016 Mar 28.


Family history tools for primary care are not ready yet to be implemented. A systematic review.

de Hoog CL, Portegijs PJ, Stoffers HE.

Eur J Gen Pract. 2014 Jun;20(2):125-33. doi: 10.3109/13814788.2013.840825. Epub 2013 Oct 25. Review.


Quantitative proteomic analysis of type III secretome of enteropathogenic Escherichia coli reveals an expanded effector repertoire for attaching/effacing bacterial pathogens.

Deng W, Yu HB, de Hoog CL, Stoynov N, Li Y, Foster LJ, Finlay BB.

Mol Cell Proteomics. 2012 Sep;11(9):692-709. doi: 10.1074/mcp.M111.013672. Epub 2012 Jun 1.


Rapid angiogenesis onset after discontinuation of sunitinib treatment of renal cell carcinoma patients.

Griffioen AW, Mans LA, de Graaf AMA, Nowak-Sliwinska P, de Hoog CLMM, de Jong TAM, Vyth-Dreese FA, van Beijnum JR, Bex A, Jonasch E.

Clin Cancer Res. 2012 Jul 15;18(14):3961-3971. doi: 10.1158/1078-0432.CCR-12-0002. Epub 2012 May 9.


The pathogenic Escherichia coli type III secreted protease NleC degrades the host acetyltransferase p300.

Shames SR, Bhavsar AP, Croxen MA, Law RJ, Mak SH, Deng W, Li Y, Bidshari R, de Hoog CL, Foster LJ, Finlay BB.

Cell Microbiol. 2011 Oct;13(10):1542-57. doi: 10.1111/j.1462-5822.2011.01640.x. Epub 2011 Aug 4.


Quantitative mass spectrometry catalogues Salmonella pathogenicity island-2 effectors and identifies their cognate host binding partners.

Auweter SD, Bhavsar AP, de Hoog CL, Li Y, Chan YA, van der Heijden J, Lowden MJ, Coombes BK, Rogers LD, Stoynov N, Foster LJ, Finlay BB.

J Biol Chem. 2011 Jul 8;286(27):24023-35. doi: 10.1074/jbc.M111.224600. Epub 2011 May 12.


The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signalling.

Shames SR, Deng W, Guttman JA, de Hoog CL, Li Y, Hardwidge PR, Sham HP, Vallance BA, Foster LJ, Finlay BB.

Cell Microbiol. 2010 Sep 1;12(9):1322-39. doi: 10.1111/j.1462-5822.2010.01470.x. Epub 2010 Mar 31.


A comprehensive proteomic analysis of the type III secretome of Citrobacter rodentium.

Deng W, de Hoog CL, Yu HB, Li Y, Croxen MA, Thomas NA, Puente JL, Foster LJ, Finlay BB.

J Biol Chem. 2010 Feb 26;285(9):6790-800. doi: 10.1074/jbc.M109.086603. Epub 2009 Dec 24.


A mammalian organelle map by protein correlation profiling.

Foster LJ, de Hoog CL, Zhang Y, Zhang Y, Xie X, Mootha VK, Mann M.

Cell. 2006 Apr 7;125(1):187-99.



de Hoog CL, Mann M.

Annu Rev Genomics Hum Genet. 2004;5:267-93. Review.


Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors.

Foster LJ, De Hoog CL, Mann M.

Proc Natl Acad Sci U S A. 2003 May 13;100(10):5813-8. Epub 2003 Apr 30.


Ras binding triggers ubiquitination of the Ras exchange factor Ras-GRF2.

de Hoog CL, Koehler JA, Goldstein MD, Taylor P, Figeys D, Moran MF.

Mol Cell Biol. 2001 Mar;21(6):2107-17.


The guanine nucleotide exchange factor CNrasGEF activates ras in response to cAMP and cGMP.

Pham N, Cheglakov I, Koch CA, de Hoog CL, Moran MF, Rotin D.

Curr Biol. 2000 May 4;10(9):555-8. Erratum in: Curr Biol 2000 Jul 27-Aug 10;10(15):R577-8.


Calmodulin-independent coordination of Ras and extracellular signal-regulated kinase activation by Ras-GRF2.

de Hoog CL, Fan WT, Goldstein MD, Moran MF, Koch CA.

Mol Cell Biol. 2000 Apr;20(8):2727-33.


The exchange factor Ras-GRF2 activates Ras-dependent and Rac-dependent mitogen-activated protein kinase pathways.

Fan WT, Koch CA, de Hoog CL, Fam NP, Moran MF.

Curr Biol. 1998 Jul 30-Aug 13;8(16):935-8.

Supplemental Content

Loading ...
Support Center